BioNTech's updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

The Department of Health and Human Services will soon restart its program of offering free rapid tests for the virus through ...

These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

PFE along with BioNTech SE BNTX announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and olderData demonstrate that the Omicron KP.2-adapted COVID ...

Targeting the KP.2 strain is expected to provide better protection against COVID-19 based on current data. The 2024-2025 mRNA COVID-19 vaccines will include a monovalent component that corresponds to ...

They are Pfizer's Comirnaty, which is also an mRNA vaccine, as well as Novavax's protein-based vaccine. "Health Canada anticipates issuing a decision regarding the Novavax and Pfizer COVID-19 ...